NCT04505618View on ClinicalTrials.gov

Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease

NARecruitingINTERVENTIONAL
Enrollment

1,050

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

June 1, 2026

Study Completion Date

September 1, 2026

Conditions
Diabetic RetinopathyRetinal Vein OcclusionHypertension,EssentialRetinal Vascular Disorder
Interventions
DEVICE

Swept-Source (SS) OCT Angiography

Non-invasive, minimal risk, ocular imaging study

DEVICE

Spectral-Domain (SD) OCT Angiography

Non-invasive, minimal risk, ocular imaging study

DEVICE

Fundus Imaging

Non-invasive, minimal risk, ocular imaging study

DEVICE

Axial Length Measurement Device

Non-invasive, minimal risk, ocular imaging study

Trial Locations (1)

21287

RECRUITING

Wilmer Eye Institute, Baltimore

All Listed Sponsors
collaborator

National Eye Institute (NEI)

NIH

lead

Johns Hopkins University

OTHER